Steven Bellon
Equibles does not estimate personal net worth.
Get an email with a short summary when Foghorn Therapeutics Inc. publishes a filing, an earnings call transcript or a press release.
Get FHTX alertsAbout Steven Bellon
Steven Bellon is recorded as CTO at Foghorn Therapeutics Inc. (FHTX) since January 10, 2022. The proxy statement of Foghorn Therapeutics Inc. reports total compensation of $1,199,455 for Steven Bellon in fiscal 2025, including a base salary of $505,000. Disclosed compensation is on record for 4 fiscal years. Foghorn Therapeutics Inc. is classified in the Biotechnology industry within the Healthcare sector. Other leadership on record at Foghorn Therapeutics Inc. includes Adrian Gottschalk (CEO and Board Member), Jeff Sacher (CFO), Kristian F. Humer (CFO and Chief Accounting Officer) and 7 others.
Affiliation history
-
Current
2022-01-10–present
-
Foghorn Therapeutics Inc. (FHTX)
Proxy statement
CurrentStart not stated–present
Last confirmed April 30, 2026
Company network
Leadership on record at Foghorn Therapeutics Inc.
- Adrian Gottschalk CEO, Board Member
- Jeff Sacher CFO
- Kristian F. Humer CFO, Chief Accounting Officer
- Ryan D. Maynard CFO
- Ryan Maynard CFO
- Stephen J. DiPalma CFO
- B. Lynne Parshall Board Member
- Ian F. Smith Board Member
- Neil J. Gallagher, M.D., Ph.D. Board Member
- Stuart Duty Board Member
Executive compensation
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2025 | Foghorn Therapeutics Inc. (FHTX) | Chief Science Officer | $505,000 | $1,199,455 |
| 2024 | Foghorn Therapeutics Inc. (FHTX) | Chief Science Officer | $485,000 | $902,212 |
| 2023 | Foghorn Therapeutics Inc. (FHTX) | Ph.D.. Chief Scientific Officer | $445,000 | $1,187,494 |
| 2022 | Foghorn Therapeutics Inc. (FHTX) | Ph.D.. Chief Scientific Officer | $435,000 | $2,145,667 |
Recent activity
No call appearances or filed executive changes recorded yet.